Factors Associated with Fatigue in COVID-19 ICU Survivors.


Journal

Medicine and science in sports and exercise
ISSN: 1530-0315
Titre abrégé: Med Sci Sports Exerc
Pays: United States
ID NLM: 8005433

Informations de publication

Date de publication:
14 Apr 2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: aheadofprint

Résumé

Approximately 30% of people infected with COVID-19 require hospitalization and 20% of them are admitted to an intensive care unit (ICU). Most of these patients experience symptoms of fatigue weeks post-ICU, so understanding the factors associated with fatigue in this population is crucial. Fifty-nine patients [38-78 yr] hospitalized in ICU for COVID-19 infection for 32 [6-80] days including 23 [3-57] days of mechanical ventilation, visited the laboratory on two separate occasions. The first visit occurred 52 ± 15 days after discharge and was dedicated to questionnaires, blood sampling and cardiopulmonary exercise testing, while measurements of the knee extensors neuromuscular function and performance fatigability were performed in the second visit 7 ± 2 days later. Using the FACIT-F questionnaire, 56% of patients were classified as fatigued. Fatigued patients had worse lung function score than non- fatigued (i.e. 2.9 ± 0.8 L vs 3.6 ± 0.8 L; 2.4 ± 0.7 l vs 3.0 ± 0.7 L for forced vital capacity and forced expiratory volume in one second, respectively) and forced vital capacity was identified as a predictor of being fatigued. Maximal voluntary activation was lower in fatigued patients than non-fatigued patients (82 ± 14% vs 91 ± 3%) and was the only neuromuscular variable that discriminated between fatigued and non-fatigued patients. Patient-reported outcomes also showed differences between fatigued and non-fatigued patients for sleep, physical activity, depression and quality of life (p < 0.05). COVID-19 survivors showed altered respiratory function 4 to 8 weeks after discharge, that was further deteriorated in fatigued patients. Fatigue was also associated with lower voluntary activation and patient-reported impairments (i.e. sleep satisfaction, quality of life or depressive state). The present study reinforces the importance of exercise intervention and rehabilitation to counteract cardiorespiratory and neuromuscular impairments of COVID-19 patients admitted in ICU, especially individuals experiencing fatigue.

Identifiants

pubmed: 38742855
doi: 10.1249/MSS.0000000000003455
pii: 00005768-990000000-00530
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American College of Sports Medicine.

Déclaration de conflit d'intérêts

Conflict of Interest and Funding Source: This study was funded by a fellowship grant and a COVID funding from IDEX Lyon (ref 2018/07/PIA-0022). The authors have no conflict of interest in relation to the present scientific paper.

Auteurs

Djahid Kennouche (D)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Clément Foschia (C)

Service de Physiologie Clinique et de l'Exercice, Hôpital Universitaire de Saint-Etienne, Saint-Etienne, France.

Callum G Brownstein (CG)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Thomas Lapole (T)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Diana Rimaud (D)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Nicolas Royer (N)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Franck Le Mat (F)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Guillaume Thiery (G)

Service de médecine intensive réanimation, Centre Hospitalier Universitaire de Saint-Etienne, Saint-Etienne & Research on Healthcare Performance RESHAPE, INSERM U1290, Université Claude Bernard Lyon 1, FRANCE.

Vincent Gauthier (V)

Réanimation, Clinique Mutualiste, Saint Etienne, FRANCE.

Pascal Giraux (P)

CHU Saint-Etienne, Service Médecine Physique et Réadaptation, Saint-Etienne, FRANCE.

Lydia Oujamaa (L)

Service de rééducation post-réanimation SRPR 42, Groupement de coopération sanitaire Fondation Partage et Vie & Centre hospitalier universitaire de Saint Etienne, Saint-Etienne, FRANCE.

Marine Sorg (M)

Service de Physiologie Clinique et de l'Exercice, Hôpital Universitaire de Saint-Etienne, Saint-Etienne, France.

Samuel Verges (S)

Univ. Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 laboratory, Grenoble, FRANCE.

Stéphane Doutreleau (S)

Univ. Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 laboratory, Grenoble, FRANCE.

Mathieu Marillier (M)

Univ. Grenoble Alpes, INSERM U1300, CHU Grenoble Alpes, HP2 laboratory, Grenoble, FRANCE.

Mélanie Prudent (M)

Service d'Explorations Fonctionnelles Respiratoires-Médecine du sport et de l'activité physique, Hospices Civils de Lyon, Lyon, FRANCE.

Laurent Bitker (L)

Service de Médecine Intensive - réanimation, hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France & Univ Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS, Inserm, Villeurbanne, FRANCE.

Léonard Féasson (L)

Université Jean Monnet Saint-Etienne, Inter-university Laboratory of Human Movement Biology, Saint-Etienne, France.

Laurent Gergelé (L)

Ramsay Générale de Santé, Hôpital privé de la Loire, Saint-Etienne, FRANCE.

Emeric Stauffer (E)

Service d'Explorations Fonctionnelles Respiratoires-Médecine du sport et de l'activité physique, Hospices Civils de Lyon, Lyon, FRANCE.

Céline Guichon (C)

Département Anesthésie Réanimation, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, FRANCE.

Julien Gondin (J)

Univ Lyon, CNRS 5261, INSERM U1315, Institut NeuroMyoGène (INMG), Unité de Physiopathologie et Génétique du Neurone et du Muscle, Lyon, FRANCE.

Classifications MeSH